## HIG: The Hartford Insurance Group, I - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.41 indicates fundamental undervaluation. Quality metrics strong (ROE 20%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($130.92)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Russell Investments Group Ltd. Trims Stake in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251130T111057 | Somewhat-Bullish | Relevance: 99%
- Russell Investments Group Ltd. trimmed its stake in The Hartford Insurance Group, Inc. (NYSE:HIG) by 13.0% in the second quarter, selling 52,612 shares and ending with 351,998 shares valued at approximately $44.57 million. Despite this reduction, analysts maintain a "Moderate Buy" consensus with an average price target of $143.29, following the company's beat on earnings and a dividend increase. The article also details other institutional investor activity, analyst ratings, stock performance, and recent insider transactions.

**2. The Hartford Insurance Group, Inc. $HIG Shares Acquired by Vinva Investment Management Ltd**
- Source: MarketBeat | 20251130T131048 | Bullish | Relevance: 99%
- Vinva Investment Management Ltd significantly increased its stake in The Hartford Insurance Group, Inc. by 33.8%, now holding 19,171 shares worth $2.39 million. Several other major institutional investors also boosted their positions, contributing to an overall institutional ownership of 93.42%. The company reported strong financial performance, beating quarterly EPS expectations and raising its quarterly dividend.

**3. AMJ Financial Wealth Management Has $10.70 Million Stake in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251202T083224 | Somewhat-Bullish | Relevance: 99%
- AMJ Financial Wealth Management increased its stake in The Hartford Insurance Group, Inc. (NYSE:HIG) by 47.0% in the 2nd quarter, now holding 84,362 shares valued at $10.70 million. Other institutional investors also adjusted their positions in HIG, which has a "Moderate Buy" consensus rating from analysts with an average target price of $143.29. The company recently increased its quarterly dividend to $0.60 per share and reported strong Q3 earnings, beating analyst estimates.

**4. Prossimo Advisors LLC Reduces Stock Position in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251202T120952 | Somewhat-Bullish | Relevance: 98%
- Prossimo Advisors LLC reduced its stake in The Hartford Insurance Group (HIG) by 33.1% in Q2, while institutional ownership remains high with significant new investments from other firms. The Hartford also reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. The article details insider transactions, stock performance metrics, and recent analyst ratings for HIG.

**5. Norges Bank Purchases New Position in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251201T115032 | Bullish | Relevance: 98%
- Norges Bank acquired a new position of 3,990,925 shares in The Hartford Insurance Group (NYSE:HIG) during the second quarter, valued at approximately $506.3 million, giving them about 1.42% ownership. The Hartford recently reported strong quarterly EPS, beating estimates with $3.78, and increased its quarterly dividend to $0.60. Market analysts currently rate HIG as a "Moderate Buy" with an average price target of $143.29.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $155 | $151 | +3% |
| 2025-11-25 | Argus Research | $155 | $143 | +8% |
| 2025-11-17 | Morgan Stanley | $150 | $140 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Buy |
| 2025-11-25 | Argus Research | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-0.8%)
- Blackrock Inc.: 10.9% (-4.4%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.9% (+13.2%)
- Price (T.Rowe) Assoc: 3.1% (-11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Quality metrics strong (ROE 20%). Balance sheet: strong liquidity (17.8x), $1.8B free cash flow. Analyst sentiment positive (3 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.6B |
| Beta | 0.63 |
| 52W Range | $104.93 - $138.64 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 10.2 |
| Current P/E | 10.7 |
| YoY Growth | 5.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.6% to -0.3% (-5.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.28% (CS: 57) | Neutral |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $135.10
- **Stop Loss:** $130.92 (3.1% risk)
- **Target:** $143.46 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 119
- **Position Value:** $16,076.90
- **Portfolio %:** 16.08%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $3.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.21 | $3.78 | +17.6% |
| 2025Q2 | $2.83 | $3.41 | +20.4% |
| 2025Q1 | $2.15 | $2.20 | +2.5% |
| 2024Q4 | $2.64 | $2.94 | +11.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*